RECURRENT BREAST CANCER
Clinical trials for RECURRENT BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BREAST CANCER trials appear
Sign up with your email to follow new studies for RECURRENT BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo tackles Hard-to-Treat breast cancer
Disease control Recruiting nowThis early-stage study tests two drugs, palbociclib and avelumab, together for people with a specific type of advanced breast cancer (AR+ triple negative). The main goals are to find the safest doses and see if the combination can shrink tumors. About 45 participants will take pa…
Matched conditions: RECURRENT BREAST CANCER
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New combo therapy aims to control advanced breast cancer
Disease control Recruiting nowThis study tests a drug called alisertib combined with hormone therapy for people with a common type of advanced breast cancer (HR+, HER2-). The cancer has continued to grow despite at least two prior hormone treatments. The goal is to find the best dose of alisertib and see if t…
Matched conditions: RECURRENT BREAST CANCER
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
2000 patients to fuel breast cancer discoveries
Knowledge-focused Recruiting nowThis study collects tumor samples and medical information from 2000 people with breast cancer that has spread or come back. The goal is to create a resource for researchers to learn more about how the disease progresses and responds to treatments. No new treatments are tested her…
Matched conditions: RECURRENT BREAST CANCER
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC